loader
Please Wait
Applying Filters...

Annual Sales of Ezetimibe reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 1,342Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Atozet

02 4Gadavist/Gadovist

03 2Gadovist product family

04 2Nilemdo/Nustendi

05 3Rosuzet

06 9Vytorin

07 10Zetia

08 1ZetiaTM

PharmaCompass

01

Brand Name : Gadovist product family

Ezetimibe

arrow
Discovery on Target
Not Confirmed

Brand Name : Gadovist product family

arrow
Discovery on Target
Not Confirmed

Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 466

2019 Revenue in Millions : 524

Growth (%) : -11

blank

02

Brand Name : Atozet

Ezetimibe

arrow
Discovery on Target
Not Confirmed

Brand Name : Atozet

arrow
Discovery on Target
Not Confirmed

Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 453

2019 Revenue in Millions : 391

Growth (%) : 16

blank

03

Brand Name : Vytorin

Ezetimibe

arrow
Discovery on Target
Not Confirmed

Brand Name : Vytorin

arrow
Discovery on Target
Not Confirmed

Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 183

2019 Revenue in Millions : 285

Growth (%) : -36

blank

04

Brand Name : Zetia

Ezetimibe

arrow
Discovery on Target
Not Confirmed

Brand Name : Zetia

arrow
Discovery on Target
Not Confirmed

Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 482

2019 Revenue in Millions : 590

Growth (%) : -18

blank

05

Brand Name : Gadovist product family

Ezetimibe

arrow
Discovery on Target
Not Confirmed

Brand Name : Gadovist product family

arrow
Discovery on Target
Not Confirmed

Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 460

2020 Revenue in Millions : 466

Growth (%) : 9

blank

06

Brand Name : Zetia

Ezetimibe

arrow
Discovery on Target
Not Confirmed

Brand Name : Zetia

arrow
Discovery on Target
Not Confirmed

Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 378

2020 Revenue in Millions : 482

Growth (%) : -22

blank

07

Brand Name : Rosuzet

Ezetimibe/Rosuvastatin

arrow
Discovery on Target
Not Confirmed

Brand Name : Rosuzet

arrow
Discovery on Target
Not Confirmed

Ezetimibe/Rosuvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 68

2020 Revenue in Millions : 130

Growth (%) : -48

blank

08

Brand Name : Atozet

Ezetimibe

arrow
Discovery on Target
Not Confirmed

Brand Name : Atozet

arrow
Discovery on Target
Not Confirmed

Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 458

2020 Revenue in Millions : 453

Growth (%) : 1

blank

09

Brand Name : Nilemdo/Nustendi

Ezetimibe

arrow
Discovery on Target
Not Confirmed

Brand Name : Nilemdo/Nustendi

arrow
Discovery on Target
Not Confirmed

Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 22

2020 Revenue in Millions : 0

Growth (%) : 100

blank

10

Brand Name : Vytorin

Ezetimibe

arrow
Discovery on Target
Not Confirmed

Brand Name : Vytorin

arrow
Discovery on Target
Not Confirmed

Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 164

2020 Revenue in Millions : 182

Growth (%) : -10

blank